A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant
Clinical trial NCT02547220 · TERMINATED
Trial details
- NCT number
- NCT02547220
- Sponsor
- Shire
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-20
- Primary completion
- 2019-05-31
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.